SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001235
Filing Date
2023-05-15
Accepted
2023-05-15 16:36:37
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nnvc-20230331x10q.htm   iXBRL 10-Q 1370285
2 EX-31.1 nnvc-20230331xex31d1.htm EX-31.1 12959
3 EX-31.2 nnvc-20230331xex31d2.htm EX-31.2 14161
4 EX-32.1 nnvc-20230331xex32d1.htm EX-32.1 7045
5 EX-32.2 nnvc-20230331xex32d2.htm EX-32.2 7079
  Complete submission text file 0001410578-23-001235.txt   4766153

Data Files

Seq Description Document Type Size
6 EX-101.SCH nnvc-20230331.xsd EX-101.SCH 37457
7 EX-101.CAL nnvc-20230331_cal.xml EX-101.CAL 28031
8 EX-101.DEF nnvc-20230331_def.xml EX-101.DEF 143490
9 EX-101.LAB nnvc-20230331_lab.xml EX-101.LAB 297963
10 EX-101.PRE nnvc-20230331_pre.xml EX-101.PRE 215564
50 EXTRACTED XBRL INSTANCE DOCUMENT nnvc-20230331x10q_htm.xml XML 707366
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36081 | Film No.: 23923348
SIC: 2834 Pharmaceutical Preparations